Chapter 2 provides an overview of the international regulatory landscape and explores the international dynamics of regulatory competition in regenerative medicine over a turbulent period of six years (2008-2014). The overview indicates that wealth conditions and country size in jurisdictions are associated with particular preferences for clinical research regulation. At the same time, international movements of patients and research to some extent change with regulatory politics. One dimension of this, I describe in terms of regulatory boundary-work, that is, the international politics of regulatory reputation. As a heuristic tool, ‘regulatory boundary-work’ calls for attention to how countries formulate stem cell policies through locally available political and regulatory mechanisms to articulate circumstances ‘at home’ with global regulatory trends. I argue that regulatory capitalism creates conditions that are affected by other countries, where perceived competitors benefit from what they regard as beneficial regulation. The regulation in competitor countries is seen as ‘captured’ or influenced by industry, scientists and other players. Exploring international drivers and the dynamics of regulatory competition, we see that regulatory capture takes place next to and entwined with ambitions to gain international competitive advantage as well as the interests of industry, hospitals, patients and science at home.